CYTORI THERAPEUTICS, INC DEF 14A 7-31-2014

Company

PLUS THERAPEUTICS, INC.

Filed

June 12, 2014

Period of Report

July 31, 2014

Accession Number

0001095981-14-000017

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →